Evidence map›Paper›PMID 36152492›Full record

ArticleSexual medicine2022

Penile and Scrotal Skin Measurements to Predict Final Vaginal Depth With Penile Inversion Vaginoplasty.

Shannon M Smith, Nance Yuan, Jenna Stelmar, Michael Zaliznyak, Grace Lee, Catherine Bresee, Maurice M Garcia

Open access · goldAbstract read
In one paragraph

Article in Sexual medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Shannon M SmithCedars-Sinai Medical Center, Los Angeles, Division of Urology; Los Angeles, CA, USA; Cedars-Sinai Transgender Surgery and Health Program; Los Angeles, CA, USA.
Nance YuanHuntington Plastic Surgery Institute; Pasadena, CA, USA.
Jenna StelmarCedars-Sinai Transgender Surgery and Health Program; Los Angeles, CA, USA.
Michael ZaliznyakSt Louis University School of Medicine, St. Louis, MO, USA.
Grace LeeCedars-Sinai Transgender Surgery and Health Program; Los Angeles, CA, USA.
Catherine BreseeBiostatistics and Bioinformatics Core, Cedars-Sinai Samuel Oschin Comprehensive Cancer Center Biostatistics Core; Los Angeles, CA, USA.
Maurice M GarciaCedars-Sinai Medical Center, Los Angeles, Division of Urology; Los Angeles, CA, USA; Cedars-Sinai Transgender Surgery and Health Program; Los Angeles, CA, USA; University of California San Francisco; Department of Urology and Department of Anatomy; San Francisco, CA, USA. Electronic address: maurice.garcia@cshs.org.
Cedars-Sinai Medical Center · USHuntington Medical Research Institutes · USSaint Louis University · USUniversity of California, Los Angeles · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionNo nomogram exists to predict maximum achievable neovaginal depth before penile inversion vaginoplasty (PIV) based on available penile & scrotal skin (SS). Maximal depth is important to patients and is determined by available skin and available anatomic space within the pelvis and varies with surgical technique.

aimWe endeavored to create a nomogram to predict expected postoperative vaginal depth.

methodsRetrospective review of all patients undergoing primary PIV at a single institution from June 2017 to February 2020 (n = 60). Pre-op: Dorsal penile and midline scrotal skin length were measured. Intra-op: Tubularized scrotal skin length measured on a dilator. Immediate post-op: Final vaginal depth measured with a dilator. OUTCOMES: The amount of available penile and scrotal skin was not associated with vaginal depth. The only variable that did significantly increase depth was the use of penile + scrotal skin, as compared to penile skin alone. (P < .001)

resultsIn patients who underwent PIV-SS, the final vaginal depth (13.3 ± 1.9 cm) was 87% of pre-op measured penile skin length (15.3 ±- 3.0 cm). In patients who underwent PIV+SS, pre-op penile skin length was 11.1 ± 4.7±cm and pre-op midline scrotal length was 22.8 ± 2.6 cm. with a final post-op vaginal canal depth of 15.2 ± 1.3 cm. In 45/46 (98%) surgeries utilizing SS grafts, SS tube length exceeded the length necessary to achieve maximal vaginal depth, and required trimming and discard. Given that in most cases there was an excess of SS, final post-op depth equaled the maximal vaginal depth that could be surgically dissected, and was not limited by the amount of available skin. CLINICAL IMPLICATIONS: Our findings suggest that for most patients it should not be necessary to include additional tissue sources (eg, peritoneum) to create a vaginal canal during primary vaginoplasty. STRENGTHS AND LIMITATIONS: Any penile skin that was discarded due to poor quality (eg, tight phimosis, poor viability) was not measured and accounted for. This likely resulted in a slight overestimation of the contribution of the penile skin to the final vaginal depth, but did not change the overall finding that final depth was not limited by available skin.

conclusionSS grafts, when harvested and tubularized using optimized technique, supplied an excess of skin necessary to line a vaginal canal space of maximal achievable depth. We found that additional tissue sources can, instead, be reserved for future salvage surgery if it becomes necessary to augment depth. Smith SM, Yuan N, Stelmar J, et al. Penile and Scrotal Skin Measurements to Predict Final Vaginal Depth With Penile Inversion Vaginoplasty. Sex Med 2022;10:100569.

Indexed as

Feminizing SurgeryGender Affirming SurgeryVaginoplasty

Identifiers

PMID36152492
PMCPMC9780772
OpenAlexW4296633277

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.